IPO - Biofrontera Inc.

Form Type: CORRESP

Filing Date: 2025-01-24

Corporate Action: Ipo

Type: New

Accession Number: 000149315225003596

Filing Summary: Biofrontera Inc. requested the acceleration of the effective date for its Registration Statement on Form S-1 (File No. 333-284371). The company aims for the statement to be declared effective by 4:30 p.m. Eastern time on January 28, 2025. Stephen Older and Andrew Terjesen of McGuireWoods LLP are authorized to modify or withdraw this request. Confirmation of the effective date should be communicated to Stephen Older or Andrew Terjesen.

Document Link: View Document

Form Type: S-1

Filing Date: 2025-01-17

Corporate Action: Ipo

Type: New

Accession Number: 000149315225002844

Filing Summary: Biofrontera Inc. has filed a registration statement on Form S-1 with the SEC for an initial public offering (IPO) of its securities. The company intends to offer shares of its common stock and possibly other securities as part of this IPO. The number of shares to be offered and the price range have yet to be determined. The filing signifies a key step towards going public and allows the company to raise capital from public markets to fund its ongoing business operations and growth strategy. The document outlines the business plan, use of proceeds, risk factors, and describes the current market conditions affecting the biotechnology industry. The company highlights its focus on dermatological products and its proprietary technologies in this sector, aiming to expand its market reach and improve its offerings through this offering.

Document Link: View Document